124 related articles for article (PubMed ID: 19430284)
1. The article by Kovach and Rosenfeld.
Charbel Issa P; Holz FG; Scholl HP
Retina; 2009 May; 29(5):717; author reply 717-8. PubMed ID: 19430284
[No Abstract] [Full Text] [Related]
2. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
Kovach JL; Rosenfeld PJ
Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
[TBL] [Abstract][Full Text] [Related]
3. Juxtafoveal telangiectasias.
Querques G; Delle Noci N
Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
[No Abstract] [Full Text] [Related]
4. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
5. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
[No Abstract] [Full Text] [Related]
6. Bevacizumab and retinal ischemia.
Neubauer AS; Kook D; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW; Ceklic L
Ophthalmology; 2007 Nov; 114(11):2096. PubMed ID: 17980746
[No Abstract] [Full Text] [Related]
7. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
8. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
9. Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Finger RP; Holz FG; Scholl HP
Br J Ophthalmol; 2008 Jul; 92(7):941-5. PubMed ID: 18577646
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.
Matsumoto Y; Yuzawa M
Jpn J Ophthalmol; 2010 Jul; 54(4):320-4. PubMed ID: 20700800
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
Windisch R; Kozousek V
Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
[No Abstract] [Full Text] [Related]
12. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.
Meyerle CB; Freund KB; Iturralde D; Spaide RF; Sorenson JA; Slakter JS; Klancnik JM; Fisher YL; Cooney MJ; Yannuzzi LA
Retina; 2007; 27(4):451-7. PubMed ID: 17420697
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab in the treatment of idiopathic macular telangiectasia.
Gamulescu MA; Walter A; Sachs H; Helbig H
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1189-93. PubMed ID: 18386039
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis.
Vianna RN; Squeri G; Turquetti R; Brasil OF; Burnier MN
Can J Ophthalmol; 2008 Aug; 43(4):492-3. PubMed ID: 18711476
[No Abstract] [Full Text] [Related]
15. Ranibizumab for retinal angiomatous proliferation.
Rouvas AA; Papakostas TD; Ladas ID
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1719-20. PubMed ID: 19669654
[No Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis.
Akesbi J; Brousseaud FX; Adam R; Rodallec T; Nordmann JP
Acta Ophthalmol; 2010 Mar; 88(2):e40-1. PubMed ID: 19508455
[No Abstract] [Full Text] [Related]
17. The effect of intravitreal bevacizumab in the treatment of Coats disease in children.
Lin CJ; Hwang JF; Chen YT; Chen SN
Retina; 2010 Apr; 30(4):617-22. PubMed ID: 19996822
[TBL] [Abstract][Full Text] [Related]
18. Comment of article by Matsumoto Y.
Campa C; D'Angelo S; Incorvaia C
Retina; 2008 May; 28(5):782; author reply 782-3. PubMed ID: 18463528
[No Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
20. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
